Amicus Therapeutics Provides Full-Year 2017 Strategic Outlook and Financial Guidance
Jan 09, 2017 12:30 pm UTC| Business
Strong Momentum for Galafold Launch in Europe and Multiple Global Regulatory Submissions Ahead Additional Data from Pompe Phase 1/2 Clinical Study and Top-Line Data from Phase 3 Epidermolysis Bullosa Study Expected in...
Strongbridge Biopharma plc Expands Commercial Capabilities with Two Rare Disease Executive Hires
Jan 09, 2017 12:30 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Jan. 09, 2017 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
Jan 09, 2017 12:30 pm UTC| Business
MENLO PARK, Calif., Jan. 09, 2017 -- Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s...
Jan 09, 2017 12:30 pm UTC| Business
-- Company Initiates Phase III “ADVOCATE” Clinical Trial for Complement Receptor Inhibitor Avacopan in ANCA Vasculitis; Development Path Outlined in Rare Kidney Disease for Chemokine Receptor Inhibitor ‘CCX140’ -- ...
Jan 09, 2017 12:30 pm UTC| Business
Statistically significant pharmacokinetic and pharmacodynamic differences of abuse potential were observed in the KP511.A01 Study CORALVILLE, Iowa, Jan. 09, 2017 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage...
Jan 09, 2017 12:30 pm UTC| Business
MINNEAPOLIS, Jan. 09, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases...
Jan 09, 2017 12:30 pm UTC| Business
WASHINGTON, Jan. 09, 2017 -- FTI Consulting, Inc. (NYSE:FCN) today announced the expansion of the firm’s Construction Solutions practice within the Forensic Litigation Consulting segment with the addition of eight...